What do systematic reviews say?

Platinum‐containing chemotherapy vs chemotherapy without platinum

The review found no eligible studies for this question.

• Platinum‐based chemotherapy for early triple‐negative breast cancer 2023 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Capecitabine‐containing regimens vs chemotherapy regimens without capecitabine

• Capecitabine for hormone receptor‐positive versus hormone receptor‐negative breast cancer 2021 · Cochrane Headline outcomes only
  no estimate extracted
  5 studies · 5 participants
  Low

OFS vs no OFS

• Ovarian suppression for adjuvant treatment of hormone receptor‐positive early breast cancer 2020 · Cochrane Headline outcomes only
  no estimate extracted
  5 studies · 2996 participants
  Low

Taxane‐containing chemotherapy vs any chemotherapy without taxane

• Taxanes for adjuvant treatment of early breast cancer 2019 · Cochrane Headline outcomes only
  no estimate extracted
  7 studies · 7 participants
  Low

MBSR vs usual care

• Mindfulness‐based stress reduction for women diagnosed with breast cancer 2019 · Cochrane Headline outcomes only
  no estimate extracted
  3 studies · 428 participants
  Low

Taxane followed by anthracyclines vs anthracyclines followed by taxane

The review found no eligible studies for this question.

• Sequencing of anthracyclines and taxanes in neoadjuvant and adjuvant therapy for early breast cancer 2019 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Breast surgery plus systemic treatment vs systemic treatment

The review found no eligible studies for this question.

• Breast surgery for metastatic breast cancer 2018 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Bisphosphonates vs placebo/observation

• Bisphosphonates and other bone agents for breast cancer 2017 · Cochrane Headline outcomes only
  no estimate extracted
  1 study · 124 participants
  Moderate

Bisphosphonates vs placebo/observation

• Bisphosphonates and other bone agents for breast cancer 2017 · Cochrane Headline outcomes only
  no estimate extracted
  5 studies · 1888 participants
  Moderate

Fulvestrant vs other endocrine treatment

• Fulvestrant for hormone‐sensitive metastatic breast cancer 2017 · Cochrane Headline outcomes only
  no estimate extracted
  4 studies · 4 participants
  High

Summary of findings: Non‐intensive vs intensive follow‐up

• Follow‐up strategies for women treated for early breast cancer 2016 · Cochrane Headline outcomes only
  no estimate extracted
  1 study · 639 participants
  High

Summary of findings: Decentralised vs centralised follow‐up

• Follow‐up strategies for women treated for early breast cancer 2016 · Cochrane Headline outcomes only
  no estimate extracted
  1 study · 356 participants
  High

Taxane followed by anthracyclines vs anthracyclines followed by taxane

• Sequencing of anthracyclines and taxanes in neoadjuvant and adjuvant therapy for early breast cancer 2019 · Cochrane Headline outcomes only
  no estimate extracted
  1 study · 20 participants
  Moderate

Summary of findings table ‐ Postmastectomy radiotherapy (PMRT) vs no PMRT

• Post‐mastectomy radiotherapy for women with early breast cancer and one to three positive lymph nodes 2023 · Cochrane Headline outcomes only
  no estimate extracted
  0 studies · 0 participants
  GRADE not reported

Exercise vs control

• Exercise for women receiving adjuvant therapy for breast cancer 2016 · Cochrane Headline outcomes only
  no estimate extracted
  1 study · 68 participants
  Low

Exercise vs control

• Exercise for women receiving adjuvant therapy for breast cancer 2016 · Cochrane Headline outcomes only
  no estimate extracted
  12 studies · 1012 participants
  Moderate

Intervention not reported

• Specialist breast care nurses for support of women with breast cancer 2021 · Cochrane Headline outcomes only
  no estimate extracted
  1 study · 105 participants
  Low

Intervention not reported

• Online support groups for women with breast cancer 2017 · Cochrane Headline outcomes only
  no estimate extracted
  2 studies · 140 participants
  Very low

Exercise vs control

• Exercise for women receiving adjuvant therapy for breast cancer 2016 · Cochrane Headline outcomes only
  no estimate extracted
  4 studies · 262 participants
  Low

Intervention not reported

The review found no eligible studies for this question.

• Specialist breast care nurses for support of women with breast cancer 2021 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found